- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imation begins shipping 8 x 10 DryView
Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications. Imation last month marked the
Imation last week began commercial shipments of DryView 8300,the 8 x 10 version of its DryView dry-process laser printing technology.DryView 8300 is targeted at nuclear medicine, ultrasound, andsmall-format applications.
Imation last month marked the 1000th installation of its 14x 17 DryView printer, DryView 8700. Imation donated the 1000thDryView 8700 to the Mayo Clinic Foundation in Rochester, MN. Asof October, Imation had sold 1500 DryView printers.
In other DryView news, Imation is planning to release an 11x 14 version of DryView. The new printer, to be called DryView8500, will be targeted at computed radiography applications, aswell as international markets, according to the company.
Imation last week released financial results for its thirdquarter (end-September) that indicated strong profit growth. Imationposted a profit of $11.8 million on revenues of $559.3 million.Revenues were up 2.4% compared with the same period last yearfor the 3M businesses that were later spun off to create Imation.The revenue growth was the first in 11 quarters for the businessunits, according to Imation chairman and CEO William Monahan.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
